These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7856682)

  • 21. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.
    Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Littlewood TJ; Fleming KA; Wainscoat JS
    Lancet; 1993 May; 341(8853):1147-8. PubMed ID: 8097823
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive blood group genetics in hemolytic disease of the fetus and newborn: a 10-year review of a laboratory evaluation of amniotic fluid-derived DNA.
    Seto E; Fernandes BJ; Wang C; Denomme GA
    Prenat Diagn; 2007 Nov; 27(11):1017-23. PubMed ID: 17705237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal cell recycling: diagnosis of gender and RhD genotype in the same fetal cell retrieved from maternal blood.
    Sekizawa A; Samura O; Zhen DK; Falco V; Bianchi DW
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1237-42. PubMed ID: 10561652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [RHD variant in RhD/-/ mother with anti-D makes noninvasive fetal RHD genotyping impossible].
    Orzińska A; Engel K; Łakomy M; Smolarczyk-Wodzyńska J; Lipińska A; Pelc-Kłopotowska M; Brojer E
    Ginekol Pol; 2009 Oct; 80(10):786-90. PubMed ID: 19943546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal determination of fetal RhD (rhesus positive) type by an amplification of DNA.
    Kvasnicka J; Rypácková B; Calda P; Hájek Z
    Sb Lek; 1998; 99(1):13-20. PubMed ID: 9748794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal RhD genotyping in fetal cells flow sorted from maternal blood.
    Geifman-Holtzman O; Bernstein IM; Berry SM; Holtzman EJ; Vadnais TJ; DeMaria MA; Bianchi DW
    Am J Obstet Gynecol; 1996 Mar; 174(3):818-22. PubMed ID: 8633649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal determination of fetal RhD type by DNA amplification.
    Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
    N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.
    Kacem N; Chakroun T; Moussa H; Abdelkefi S; Houissa B; Chiaroni J; Jemni Yacoub S
    Transfus Med; 2012 Oct; 22(5):362-6. PubMed ID: 22757646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal diagnosis of the Rhesus D fetal blood type on amniotic fluid in daily practice.
    Goebel JC; Soergel P; Pruggmayer M; Mühlhaus K; Stuhrmann M; Scharf A
    Arch Gynecol Obstet; 2008 Feb; 277(2):155-60. PubMed ID: 17701192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of RH and its clinical application.
    Flegel WA
    Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
    BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical models for human pre-embryo biopsy and genetic diagnosis. II. Polymerase chain reaction amplification of deoxyribonucleic acid from single lymphoblasts and blastomeres with mutation detection.
    Morsy M; Takeuchi K; Kaufmann R; Veeck L; Hodgen GD; Beebe SJ
    Fertil Steril; 1992 Feb; 57(2):431-8. PubMed ID: 1735498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prenatal determination of fetal rhesus factor in amnionic cells using polymerase chain reaction].
    Crombach G; Picard F; Beckmann MW; Niederacher D; Bender HG
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):577-9. PubMed ID: 8543131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
    Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
    Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
    Reiner AP; Teramura G; Aramaki KM
    Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.